Valeant Pharmaceuticals International, a Quebec-based drug maker, on May 28 announced it has paid about $8.7 billion to acquire Bausch & Lomb Holdings, an eye health company with pharmaceutical headquarters in Madison.
Omthera Bought for $323M
Drug manufacturer AstraZeneca in London, England, said May 29 it has purchased fellow pharmaceutical company Omthera in Princeton for about $323 million in cash and stock.
Bartelstone Glass Acquired
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
